These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12821261)

  • 21. Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.
    Makondo K; Kimura K; Kitamura N; Kitamura T; Yamaji D; Jung BD; Saito M
    Biochem J; 2003 Aug; 374(Pt 1):63-9. PubMed ID: 12757411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells.
    Lin XP; Cui HJ; Yang AL; Luo JK; Tang T
    J Vasc Res; 2018; 55(3):169-176. PubMed ID: 29972829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
    Xiao L; Dong JH; Teng X; Jin S; Xue HM; Liu SY; Guo Q; Shen W; Ni XC; Wu YM
    J Hypertens; 2018 Mar; 36(3):651-665. PubMed ID: 29084084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release.
    Fontana J; Fulton D; Chen Y; Fairchild TA; McCabe TJ; Fujita N; Tsuruo T; Sessa WC
    Circ Res; 2002 May; 90(8):866-73. PubMed ID: 11988487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K/Akt/eNOS pathway and inhibiting activation of ERK1/2 and NF-κB.
    Deng HF; Wang XL; Sun H; Xiao XZ
    Life Sci; 2017 Dec; 191():115-121. PubMed ID: 29037842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway.
    Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C
    Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of high-density lipoprotein on endothelium-dependent vasorelaxation.
    McAllister RM; Morris DM; Weimer CM; Laughlin MH
    Appl Physiol Nutr Metab; 2010 Jun; 35(3):319-27. PubMed ID: 20555376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery.
    Ndiaye M; Chataigneau M; Lobysheva I; Chataigneau T; Schini-Kerth VB
    FASEB J; 2005 Mar; 19(3):455-7. PubMed ID: 15623569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase.
    Jin ZG; Ueba H; Tanimoto T; Lungu AO; Frame MD; Berk BC
    Circ Res; 2003 Aug; 93(4):354-63. PubMed ID: 12893742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
    Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
    Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.
    Fleming I; Fisslthaler B; Dimmeler S; Kemp BE; Busse R
    Circ Res; 2001 Jun; 88(11):E68-75. PubMed ID: 11397791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCN1 acutely increases nitric oxide production via integrin αvβ3-Akt-S6K-phosphorylation of endothelial nitric oxide synthase at the serine 1177 signaling axis.
    Hwang S; Lee HJ; Kim G; Won KJ; Park YS; Jo I
    Free Radic Biol Med; 2015 Dec; 89():229-40. PubMed ID: 26393424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase.
    Hambrecht R; Adams V; Erbs S; Linke A; Kränkel N; Shu Y; Baither Y; Gielen S; Thiele H; Gummert JF; Mohr FW; Schuler G
    Circulation; 2003 Jul; 107(25):3152-8. PubMed ID: 12810615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.
    Nofer JR; van der Giet M; Tölle M; Wolinska I; von Wnuck Lipinski K; Baba HA; Tietge UJ; Gödecke A; Ishii I; Kleuser B; Schäfers M; Fobker M; Zidek W; Assmann G; Chun J; Levkau B
    J Clin Invest; 2004 Feb; 113(4):569-81. PubMed ID: 14966566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids.
    Nofer JR; Levkau B; Wolinska I; Junker R; Fobker M; von Eckardstein A; Seedorf U; Assmann G
    J Biol Chem; 2001 Sep; 276(37):34480-5. PubMed ID: 11432865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway.
    Chavakis E; Dernbach E; Hermann C; Mondorf UF; Zeiher AM; Dimmeler S
    Circulation; 2001 Apr; 103(16):2102-7. PubMed ID: 11319202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells.
    Kim YM; Namkoong S; Yun YG; Hong HD; Lee YC; Ha KS; Lee H; Kwon HJ; Kwon YG; Kim YM
    Biol Pharm Bull; 2007 Sep; 30(9):1674-9. PubMed ID: 17827719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.